Inmune Bio, Inc. SEC filings INMB
Inmune Bio, Inc. has 601 filings in SEC EDGAR's recent list, going back to Jul 13, 2017. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Apr 16, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 2, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 3, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 4, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 11, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 29, 2019 | Dec 31, 2018 |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- INMB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Boca Raton, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1711754
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.